Effect of preanalytical processing of ThinPrep specimens on detection of high-risk human papillomavirus by the Aptima HPV assay

Journal of Clinical Microbiology

Volumn 52, Issue 5, 2014, Pages 1448-1452

  Munson, Erik ^a,b   Schroeder, Elizabeth R ^a   Ross, Kevin C ^a   Yauck, Connie ^a   Bieganski, Theresa ^a   Amrhein, Robert D ^a   Napierala, Maureen ^a   Harkins, April L ^c  

^a Wheaton Franciscan Laboratory   (United States)

^b UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^c MARQUETTE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; GENOMIC DNA;

ACCURACY; ARTICLE; AUTOMATION; CONTAINER; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC TEST; DNA CONTENT; NONHUMAN; PRIORITY JOURNAL; PROCESS TECHNOLOGY; VALIDITY; VIRUS DETECTION; WART VIRUS; CHEMISTRY; FEMALE; HUMAN; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; MOLECULAR DIAGNOSIS; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; PROSPECTIVE STUDY; VAGINA SMEAR; VIROLOGY;

ACETIC ACID; FEMALE; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; SPECIMEN HANDLING; VAGINAL SMEARS;

EID: 84899570644     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03624-13     Document Type: Article

References (21)

1. Monsonego J, Hudgens MG, Zerat L, Zerat JC, Syrjänen K, Halfon P, Ruiz F, Smith JS. 2011. Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study. Int. J. Cancer 129:691-701. http://dx.doi.org/10.1002/ijc.25726.
2. Ratnam S, Coutlee F, Fontaine D, Bentley J, Escott N, Ghatage P, Gadag V, Holloway G, Bartellas E, Kum N, Giede C, Lear A. 2011. Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 assay but more specific at detecting cervical precancer and cancer. J. Clin. Microbiol. 49:557-564. http://dx.doi.org/10.1128/JCM.02147-10.
3. Clad A, Reuschenbach M, Weinschenk J, Grote R, Rahmsdorf J, Freudenberg N. 2011. Performance of the Aptima high-risk human papillomavirus mRNA assay in a referral population in comparison with Hybrid Capture 2 and cytology. J. Clin. Microbiol. 49:1071-1076. http://dx.doi.org/10.1128/JCM.01674-10.
4. Stoler MH, Wright TC, JR, Cuzick J, Dockter J, Reid JL, Getman D, Giachetti C. 2013. Aptima HPV assay performance in women with atypical squamous cells of undetermined significance cytology results. Am. J. Obstet. Gynecol. 208:144.e1-144.e8. http://dx.doi.org/10.1016/j.ajog.2012.12.003.
5. Munson E, Kroeger L, Balzer S, Amrhein R, Munson KL, Napierala M, Hudspeth R, Dillon PJ. 2014. Comparison of commercial hybridization and automated transcription-mediated amplification modalities for detectionofhigh-risk human papillomavirus nucleic acid. J. Clin. Microbiol. 52:331-334. http://dx.doi.org/10.1128/JCM.03066-13.
6. Hologic/Gen-Probe. 2013. Aptima HPV assay package insert. Hologic/Gen-Probe, Incorporated, San Diego, CA.
7. Gen-Probe. 2010. Aptima specimen transfer kit for use with PreservCyt Liquid Pap Specimens package insert. Gen-Probe, Incorporated, San Diego, CA.
8. Agoff SN, Dean T, Nixon BK, Ingalls-Severn K, Rinker L, Grieco VS. 2002. The efficacy of reprocessing unsatisfactory cervicovaginal ThinPrep specimens with and without glacial acetic acid: effectonHybrid Capture II human papillomavirus testing and clinical follow-up. Am. J. Clin. Pathol. 118:727-732. http://dx.doi.org/10.1309/GE86-156K-EGM2-DGXB.
9. Feng J, Husain M. 2005. Reflex high-risk human papillomavirus DNA testing (Hybrid Capture 2) of blood ThinPrep specimens with atypical cells of undetermined significance: does pretreatment with acetic acid affect test performance? Cancer 105:452-456. http://dx.doi.org/10.1002/cncr.21349.
10. Munson E, Du Chateau BK, Nelson BE, Griep J, Czarnecka J, Amrhein RD, Schroeder ER. 2012. Effect of glacial acetic acid treatment of liquidbased cytology collections on performance of Cervista HPV HR for detection of high-risk human papillomavirus. J. Clin. Microbiol. 50:2129-2131. http://dx.doi.org/10.1128/JCM.06719-11.
11. Hologic, Inc. 2011. ThinPrep 2000 system package insert. Hologic, Incorporated, Marlborough, MA.
12. Iverson DK, Armour LB. 2000. Reprocessing ThinPrep Pap tests. ASC Bull. 37:82-86.
13. Gaydos CA, Quinn TC, Willis D, Weissfeld A, Hook EW, Martin DH, Ferrero DV, Schachter J. 2003. Performance of the Aptima Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J. Clin. Microbiol. 41:304-309. http://dx.doi.org/10.1128/JCM. 41.1.304-309.2003.
14. Munson E, Du Chateau BK, Bellerose B, Czarnecka J, Griep J. 2011. Clinical laboratory evaluationof Invader chemistry and hybrid capture for detection of high-risk human papillomavirus in liquid-based cytology specimens. Diagn. Microbiol. Infect. Dis. 71:230-235. http://dx.doi.org/10.1016/j. diagmicrobio.2011.07.004.
15. Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, Solomon D, Wentzensen N, Lawson HW; 2012 ASCCP Consensus Guidelines Conference. 2013. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet. Gynecol. 121:829-846. http://dx.doi.org/10.1097/AOG.0b013e3182883a34.
16. Burd EM. 2010. Validation of laboratory-developed molecular assays for infectious diseases. Clin. Microbiol. Rev. 23:550-576. http://dx.doi.org/10. 1128/CMR.00074-09.
17. Nolte FS, Caliendo A. 2007. Molecular detection and identification of microorganisms, p 218-244. In Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA (ed), Manual of clinical microbiology, 9th ed. ASM Press, Washington, DC.
18. Chernesky M, Jang D, Portillo E, Smieja M, Kapala J, Doucette C, Sumner J, Ewert R, MacRitchie C, Gilchrist J. 2012. Comparison of three assays for detection of Chlamydia trachomatisand Neisseria gonorrhoeae in SurePath Pap samples and the roleofpre- and postcytology testing. J. Clin. Microbiol. 50:1281-1284. http://dx.doi.org/10.1128/JCM.06595-11.
19. Dockter J, Schroder A, Eaton B, Wang A, Sikhamsay N, Morales L, Giachetti C. 2009. Analytical characterization of the Aptima HPV assay. J. Clin. Virol. 45(Suppl 1):S39-S47. http://dx.doi.org/10.1016/S1386-6532 (09) 70007-1.
20. Hologic/Gen-Probe, Inc. 2013. Aptima specimen transfer kit for use with ThinPrep liquid cytology specimens package insert. Hologic/Gen-Probe, Incorporated, San Diego, CA.
21. College of American Pathologists Accreditation Program. 2013. Molecular pathology checklist. College of American Pathologists, Northfield, IL.